We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
-19.73%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$11.1B
AUM Growth
-$2.57B
Cap. Flow
+$671M
Cap. Flow %
6.05%
Top 10 Hldgs %
19.98%
Holding
128
New
9
Increased
85
Reduced
25
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 24.88%
2 Technology 21.16%
3 Financials 14.01%
4 Consumer Staples 13.48%
5 Industrials 12.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTNX icon
76
Nutanix
NTNX
$16B
$57.7M 0.52%
3,649,190
-540,895
-13% -$15.2M
ATRC icon
77
AtriCure
ATRC
$1.92B
$56.9M 0.51%
1,693,225
+443,585
+35% +$15.9M
SAM icon
78
Boston Beer
SAM
$1.91B
$54M 0.49%
146,950
+53,015
+56% +$19.7M
INSP icon
79
Inspire Medical Systems
INSP
$1.45B
$52.5M 0.47%
870,320
+207,355
+31% +$15.3M
PEN icon
80
Penumbra
PEN
$12.6B
$52.4M 0.47%
324,660
+55,035
+20% +$9.27M
WWW icon
81
Wolverine World Wide
WWW
$1.61B
$51.6M 0.46%
3,396,895
+689,300
+25% +$19M
CVBF icon
82
CVB Financial
CVBF
$3.94B
$51.5M 0.46%
2,566,645
-27,895
-1% -$561K
AIMC
83
DELISTED
Altra Industrial Motion Corp
AIMC
$51.4M 0.46%
2,937,905
+86,205
+3% +$2.56M
CBSH icon
84
Commerce Bancshares
CBSH
$8.53B
$49M 0.44%
1,304,651
-486,234
-27% -$23M
TRS icon
85
TriMas Corp
TRS
$1.43B
$48.4M 0.44%
2,094,140
+470,215
+29% +$12.9M
IOSP icon
86
Innospec
IOSP
$2.12B
$47.4M 0.43%
682,775
+18,130
+3% +$1.66M
BL icon
87
BlackLine
BL
$1.84B
$45.6M 0.41%
866,670
-219,200
-20% -$12.8M
TXRH icon
88
Texas Roadhouse
TXRH
$13.5B
$44.8M 0.4%
1,085,365
+472,775
+77% +$26.1M
JRVR icon
89
James River Group Holdings
JRVR
$208M
$44.6M 0.4%
1,230,875
+2,655
+0.2% +$107K
NVST icon
90
Envista
NVST
$4.44B
$40.9M 0.37%
2,736,755
+922,950
+51% +$23.6M
WBT
91
DELISTED
Welbilt, Inc.
WBT
$40.5M 0.37%
7,903,386
-3,804
-0% -$45.8K
SBH icon
92
Sally Beauty Holdings
SBH
$1.43B
$39.9M 0.36%
4,933,205
-4,026,925
-45% -$53.5M
SXI icon
93
Standex International
SXI
$3.59B
$39.8M 0.36%
812,695
+365
+0% +$24K
FUL icon
94
H.B. Fuller
FUL
$2.97B
$39.7M 0.36%
1,419,740
-193,100
-12% -$8.11M
MGPI icon
95
MGP Ingredients
MGPI
$379M
$37.2M 0.34%
1,383,915
-22,505
-2% -$769K
CHD icon
96
Church & Dwight Co
CHD
$23.4B
$36.6M 0.33%
+570,525
New +$40.5M
MORN icon
97
Morningstar
MORN
$7.22B
$36.1M 0.33%
310,460
+3,765
+1% +$546K
BIO icon
98
Bio-Rad Laboratories Class A
BIO
$8.71B
$36M 0.32%
+102,725
New +$37.8M
ELF icon
99
e.l.f. Beauty
ELF
$4.89B
$35.8M 0.32%
3,643,000
-1,615
-0% -$24.2K
EYE icon
100
National Vision
EYE
$1.77B
$33.5M 0.3%
1,726,160
-15,055
-0.9% -$469K

Similar funds

Champlain Investment Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Champlain Investment Partners held 128 positions worth $11.1B, down 19% from $13.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Champlain Investment Partners deployed $671M of net new capital in Q1 2020, opening 9 new positions and adding to 85 existing holdings. Its largest new stake was Dunkin' Brands Group, Inc.: 1,501,060 shares worth $79.7M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Teladoc Health, an estimated $122M trimmed.

  • Champlain Investment Partners's largest Q1 2020 buy was Dunkin' Brands Group, Inc.: 1,501,060 shares worth $79.7M.
  • Champlain Investment Partners added most to Medallia, Inc. in Q1 2020, an estimated $127M increase.
  • Champlain Investment Partners's biggest Q1 2020 reduction was Teladoc Health, cutting an estimated $122M.
  • Champlain Investment Partners fully exited Labcorp in Q1 2020, selling an estimated $132M.
  • Champlain Investment Partners's ten largest holdings make up 20% of its $11.1B portfolio in Q1 2020.
  • Champlain Investment Partners opened 9 new positions and closed 9 in Q1 2020.
  • Champlain Investment Partners's portfolio value fell 19% quarter-over-quarter to $11.1B.

Based on Champlain Investment Partners's 13F filing for Q1 2020, filed 14 May 2020.